Zoom colonoscopy market seen reaching $1.93B by 2030

The global zoom colonoscopy market is projected to grow from $1.41 billion in 2026 to $1.93 billion by 2030, driven by rising colorectal disease rates, broader screening use and more advanced imaging tools. North America leads today, while Asia-Pacific is expected to grow fastest as healthcare systems expand.

Why it matters: - Zoom colonoscopy is used to spot subtle polyps, early cancers and inflammatory changes in the colon and rectum. - Faster diagnosis and better visualization can support earlier treatment and improve patient outcomes. - The market’s growth tracks with rising demand for early cancer detection, preventive diagnostics and minimally invasive procedures.

What happened: - The zoom colonoscopy market rose from $1.29 billion in 2025 to an estimated $1.41 billion in 2026. - The market is forecast to reach $1.93 billion by 2030. - The projected 2026-2030 compound annual growth rate is 8.3%. - The Business Research Company published the market outlook on Sept. 24, 2026. - The report says North America held the largest market share in 2025. - The report says Asia-Pacific is expected to be the fastest-growing region over the forecast period.

The details: - Zoom colonoscopy uses a high-magnification endoscope to provide a detailed view of the colon and rectal lining. - The technology is positioned as a tool for earlier and more precise detection of gastrointestinal disease. - The market’s recent expansion has been supported by more colorectal cancer cases worldwide, wider adoption of endoscopic screening programs, stronger awareness of early detection and growth in hospital diagnostic infrastructure. - Future demand is tied to AI-enabled medical imaging, more ambulatory surgical and diagnostic centers, an aging population and advances in minimally invasive gastrointestinal procedures. - Emerging trends include high-definition and zoom-enabled endoscopy systems, AI-based polyp detection, robotic-assisted endoscopy, capsule endoscopy and advanced visualization tools. - Rising colorectal disease rates are a key growth driver. - In February 2026, the UK Office for National Statistics reported 15,552 colorectal cancer deaths in England and Wales in 2023 and a provisional 15,553 deaths for 2024. - Rising gastrointestinal disorders are also increasing demand for advanced diagnostics. - In July 2025, the CDC reported norovirus GII.17 outbreaks rose from under 10% in the 2022-23 season to about 75% in the 2024-25 season. - Hospital infrastructure growth is supporting demand for colorectal screening and diagnostics. - The American Hospital Association said U.S. hospitals increased from 6,093 in fiscal 2022 to 6,120 in fiscal 2024.

Between the lines: - The market forecast points to a broader shift toward earlier detection and more precise screening in gastrointestinal care. - AI and robotics are moving from adjacent technologies to core parts of the colonoscopy workflow. - North America’s lead suggests mature infrastructure and faster adoption, while Asia-Pacific’s growth reflects new investment and expanding access.

What's next: - Continued hospital and ambulatory center expansion should add more sites for screening and diagnostic procedures. - More AI-enabled imaging and robotic-assisted systems are likely to shape product development and purchasing decisions. - The next phase of growth will likely depend on how quickly providers adopt advanced visualization tools and preventive screening programs.

The bottom line: - Zoom colonoscopy is moving from a specialized diagnostic tool to a growth market shaped by cancer screening, aging populations and better imaging technology.